Toby Pepperrell

702 total citations
12 papers, 353 citations indexed

About

Toby Pepperrell is a scholar working on Infectious Diseases, Epidemiology and Economics and Econometrics. According to data from OpenAlex, Toby Pepperrell has authored 12 papers receiving a total of 353 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 5 papers in Epidemiology and 3 papers in Economics and Econometrics. Recurrent topics in Toby Pepperrell's work include HIV/AIDS Research and Interventions (5 papers), SARS-CoV-2 and COVID-19 Research (4 papers) and HIV/AIDS drug development and treatment (3 papers). Toby Pepperrell is often cited by papers focused on HIV/AIDS Research and Interventions (5 papers), SARS-CoV-2 and COVID-19 Research (4 papers) and HIV/AIDS drug development and treatment (3 papers). Toby Pepperrell collaborates with scholars based in United Kingdom, Netherlands and South Africa. Toby Pepperrell's co-authors include Andrew Hill, Victoria Pilkington, Sarai Keestra, Kaitlyn McCann, François Venter, Anton Pozniak, Henna Reddy, Sophie Hughes, Dzintars Gotham and Junzheng Wang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Infectious Diseases and AIDS.

In The Last Decade

Toby Pepperrell

12 papers receiving 344 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Toby Pepperrell United Kingdom 9 235 64 58 35 30 12 353
Victoria Pilkington United Kingdom 10 290 1.2× 105 1.6× 60 1.0× 47 1.3× 40 1.3× 15 457
Paola Magro Italy 7 172 0.7× 39 0.6× 28 0.5× 33 0.9× 40 1.3× 14 277
Gil Lavie Israel 10 233 1.0× 118 1.8× 80 1.4× 141 4.0× 120 4.0× 29 512
Jocelyn Voell United States 8 171 0.7× 185 2.9× 28 0.5× 46 1.3× 8 0.3× 8 480
Sarah M. Michienzi United States 11 175 0.7× 63 1.0× 17 0.3× 17 0.5× 41 1.4× 25 297
Ajay Rangaraj Switzerland 9 329 1.4× 92 1.4× 32 0.6× 25 0.7× 90 3.0× 20 430
Agam Vora India 8 277 1.2× 92 1.4× 72 1.2× 85 2.4× 16 0.5× 43 498
Hippolyte Situakibanza Democratic Republic of the Congo 9 122 0.5× 73 1.1× 15 0.3× 7 0.2× 23 0.8× 37 207
Emili Letang Spain 7 151 0.6× 41 0.6× 44 0.8× 42 1.2× 8 0.3× 8 336
Naser Nasiri Iran 11 165 0.7× 93 1.5× 89 1.5× 12 0.3× 2 0.1× 41 480

Countries citing papers authored by Toby Pepperrell

Since Specialization
Citations

This map shows the geographic impact of Toby Pepperrell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toby Pepperrell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toby Pepperrell more than expected).

Fields of papers citing papers by Toby Pepperrell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Toby Pepperrell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toby Pepperrell. The network helps show where Toby Pepperrell may publish in the future.

Co-authorship network of co-authors of Toby Pepperrell

This figure shows the co-authorship network connecting the top 25 collaborators of Toby Pepperrell. A scholar is included among the top collaborators of Toby Pepperrell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Toby Pepperrell. Toby Pepperrell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Pepperrell, Toby, et al.. (2024). Lower Prevalence Countries Outside of South-Eastern Africa Now Have the Fastest Growing HIV Epidemic. Open Forum Infectious Diseases. 11(7). ofae318–ofae318. 1 indexed citations
2.
Mpoudi-Etame, Mireille, Charles Kouanfack, Éric Delaporte, et al.. (2023). Risks of metabolic syndrome in the ADVANCE and NAMSAL trials. SHILAP Revista de lepidopterología. 5. 1133556–1133556. 11 indexed citations
3.
Pilkington, Victoria, et al.. (2022). Efficacy of Approved Versus Unapproved Vaccines for Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Randomized Blinded Clinical Trials. Open Forum Infectious Diseases. 9(9). ofac408–ofac408. 3 indexed citations
4.
Pepperrell, Toby, et al.. (2022). Barriers to Worldwide Access for Paxlovid, a New Treatment for COVID-19. Open Forum Infectious Diseases. 9(9). ofac174–ofac174. 12 indexed citations
5.
Pepperrell, Toby, et al.. (2022). Cabotegravir—Global Access to Long-Acting Pre-exposure Prophylaxis for HIV. Open Forum Infectious Diseases. 10(1). ofac673–ofac673. 10 indexed citations
6.
Reddy, Henna, et al.. (2021). Who funded the research behind the Oxford–AstraZeneca COVID-19 vaccine?. BMJ Global Health. 6(12). e007321–e007321. 40 indexed citations
7.
Pepperrell, Toby, et al.. (2021). Missing clinical trial data: the evidence gap in primary data for potential COVID-19 drugs. Trials. 22(1). 59–59. 15 indexed citations
8.
Pepperrell, Toby, et al.. (2021). Making a COVID-19 vaccine that works for everyone: ensuring equity and inclusivity in clinical trials. Global Health Action. 14(1). 1892309–1892309. 15 indexed citations
9.
Pepperrell, Toby, François Venter, Kaitlyn McCann, et al.. (2021). Participants on Dolutegravir Resuppress Human Immunodeficiency Virus RNA After Virologic Failure: Updated Data from the ADVANCE Trial. Clinical Infectious Diseases. 73(4). e1008–e1010. 17 indexed citations
10.
Pilkington, Victoria, Toby Pepperrell, & Andrew Hill. (2020). A review of the safety of favipiravir – a potential treatment in the COVID-19 pandemic?. Journal of Virus Eradication. 6(2). 45–51. 196 indexed citations
11.
Pilkington, Victoria, Sophie Hughes, Toby Pepperrell, et al.. (2020). Tenofovir alafenamide vs. tenofovir disoproxil fumarate: an updated meta-analysis of 14 894 patients across 14 trials. AIDS. 34(15). 2259–2268. 28 indexed citations
12.
Cohen, Jennifer, Toby Pepperrell, & François Venter. (2020). The same lesson over and over: drugs alone will not get us to 90--90--90. AIDS. 34(6). 943–946. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Victoria Pilkington Breakdown of academic impact, for papers by Paola Magro Breakdown of academic impact, for papers by Gil Lavie Breakdown of academic impact, for papers by Jocelyn Voell Breakdown of academic impact, for papers by Sarah M. Michienzi Breakdown of academic impact, for papers by Ajay Rangaraj Breakdown of academic impact, for papers by Agam Vora Breakdown of academic impact, for papers by Hippolyte Situakibanza Breakdown of academic impact, for papers by Emili Letang Breakdown of academic impact, for papers by Naser Nasiri
Rankless by CCL
2026